American Century Companies’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-197,704
| Closed | -$326K | – | 2908 |
|
|
2024
Q4 | $326K | Buy |
197,704
+12,295
| +7% | +$20.3K | ﹤0.01% | 2655 |
|
|
2024
Q3 | $649K | Buy |
185,409
+19,154
| +12% | +$67K | ﹤0.01% | 2382 |
|
|
2024
Q2 | $545K | Buy |
166,255
+34,676
| +26% | +$114K | ﹤0.01% | 2410 |
|
|
2024
Q1 | $966K | Buy |
131,579
+78,597
| +148% | +$577K | ﹤0.01% | 2164 |
|
|
2023
Q4 | $198K | Buy |
52,982
+15,920
| +43% | +$59.5K | ﹤0.01% | 2696 |
|
|
2023
Q3 | $78.6K | Buy |
37,062
+15,848
| +75% | +$33.6K | ﹤0.01% | 2754 |
|
|
2023
Q2 | $101K | Buy |
+21,214
| New | +$101K | ﹤0.01% | 2675 |
|
|
2023
Q1 | – | Sell |
-327,880
| Closed | -$3.31M | – | 2677 |
|
|
2022
Q4 | $3.31M | Buy |
327,880
+90,990
| +38% | +$918K | ﹤0.01% | 1384 |
|
|
2022
Q3 | $5.31M | Buy |
236,890
+1,655
| +0.7% | +$37.1K | ﹤0.01% | 1086 |
|
|
2022
Q2 | $5.83M | Buy |
235,235
+18,560
| +9% | +$460K | ﹤0.01% | 1078 |
|
|
2022
Q1 | $8.4M | Buy |
216,675
+37,090
| +21% | +$1.44M | 0.01% | 959 |
|
|
2021
Q4 | $10.5M | Buy |
179,585
+42,141
| +31% | +$2.47M | 0.01% | 863 |
|
|
2021
Q3 | $8.15M | Buy |
137,444
+7,290
| +6% | +$432K | 0.01% | 902 |
|
|
2021
Q2 | $11.3M | Buy |
130,154
+332
| +0.3% | +$28.8K | 0.01% | 786 |
|
|
2021
Q1 | $10.7M | Buy |
129,822
+117,395
| +945% | +$9.68M | 0.01% | 765 |
|
|
2020
Q4 | $1.13M | Buy |
+12,427
| New | +$1.13M | ﹤0.01% | 1225 |
|